One Stock You Should Watch
Tiny stock is straddling not one but two huge markets – read our report to learn more.
Learn more.

NRI Insider Trading (Nuvo Pharmaceuticals Inc. (NRI.TO))

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$48,166.04
Insider Selling (Last 12 Months): C$26,546.61

Nuvo Pharmaceuticals Inc. (NRI.TO) Insider Trading History Chart

This chart shows the insider buying and selling history at Nuvo Pharmaceuticals Inc. (NRI.TO) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nuvo Pharmaceuticals Inc. (NRI.TO) Share Price & Price History

Current Price: C$34.17
Price Change: Price Increase of +0.01 (0.03%)
As of 07/26/2021 01:00 AM ET

This chart shows the closing price history over time for NRI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Revealed: A Real Solution for Depression?
Depression is the leading cause of disability worldwide. For nearly 100 million people… there's no known solution. That's right. Nearly one-third of the world's 322 million people suffering from depression have no existing treatment. But that's all about to change.
Here's how you could capitalize off this

Nuvo Pharmaceuticals Inc. (NRI.TO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/23/2021Jesse Francis LedgerSenior OfficerBuy2,200C$1.46C$3,218.60116,986
6/21/2021Jesse Francis LedgerSenior OfficerBuy2,000C$1.44C$2,871.00112,086
5/28/2021Anthony Edward DobranowskiDirectorBuy6,000C$1.45C$8,700.0062,181
5/26/2021Anthony Edward DobranowskiDirectorBuy1,181C$1.50C$1,771.5056,181
5/20/2021Anthony Edward DobranowskiDirectorBuy10,000C$1.60C$16,015.0055,000
3/22/2021Jesse Francis LedgerSenior OfficerBuy4,700C$1.67C$7,849.94110,086
12/22/2020Anthony Edward DobranowskiDirectorBuy9,000C$0.86C$7,740.0019,000
11/20/2020Anthony Edward DobranowskiDirectorSell8,181C$0.81C$6,626.6110,000
11/18/2020Anthony Edward DobranowskiDirectorSell24,000C$0.83C$19,920.0018,181
6/15/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.80C$2,000.0097,386
6/12/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.79C$1,975.0094,886
6/10/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.80C$2,000.0089,886
6/4/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.80C$2,000.0079,886
5/28/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.82C$2,060.0067,386
5/25/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.79C$1,975.0059,886
5/22/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.80C$2,000.0057,386
5/20/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.80C$2,000.0052,386
5/14/2020Jesse Francis LedgerSenior OfficerBuy2,500C$0.73C$1,825.0044,886
5/14/2020Robert Paul HarrisDirectorBuy10,000C$0.70C$7,000.0050,000
3/5/2020Anthony Edward DobranowskiDirectorBuy2,915C$0.84C$2,448.6042,181
See Full Table
Insider Trading at Nuvo Pharmaceuticals Inc. (NRI.TO)?
Sign-up to receive's daily insider buying and selling report for Nuvo Pharmaceuticals Inc. (NRI.TO) and related companies.

SEC Filings (Institutional Ownership Changes) for Nuvo Pharmaceuticals Inc. (NRI.TO) (TSE:NRI)

Nuvo Pharmaceuticals Inc., a healthcare company, provides prescription and non-prescription products for pain, allergy, and dermatology in the United States, Canada, Europe, and internationally. The company operates through three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for the treatment of migraine; Resultz, a non-prescription product intended to kill head lice and remove their eggs from hair; and Suvexx/Treximet, a medicine for migraine. The company also provides Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid; Vimovo for relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; Yosprala for secondary prevention of cardiovascular and cerebrovascular events; and Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch applied prior to painful medical procedures, such as venous access, blood draws, needle injections and minor dermatologic surgical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Read More on Nuvo Pharmaceuticals Inc. (NRI.TO)

Today's Range

Now: C$34.17
Low: C$34.17
High: C$34.18

50 Day Range

MA: C$31.89
Low: C$0.91
High: C$36.99

52 Week Range

Now: C$34.17
Low: C$0.43
High: C$1.20



Average Volume

19,371 shs

Market Capitalization

C$389.07 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Nuvo Pharmaceuticals Inc. (NRI.TO)?

Nuvo Pharmaceuticals Inc. (NRI.TO)'s top insider shareholders include:
  1. Jesse Francis Ledger (Senior Officer)
  2. Anthony Edward Dobranowski (Director)
  3. Robert Paul Harris (Director)
One Stock You Should Watch
Tiny stock is straddling not one but two huge markets – read our report to learn more.
Learn more.